Yonger Chen
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Inflammasome and immune disorders 3
- Gut microbiota and health 2
-
- Liver Disease Diagnosis and Treatment 4
- Co-authors
- Shaozhen Hou (18 shared papers)Xin Yuan (2 shared papers)Jian Liang (2 shared papers)Jian Liang (6 shared papers)Yingyu Lu (7 shared papers)Shuxian Chen (6 shared papers)Jian Liang (9 shared papers)Song Huang (6 shared papers)
- Journals
- Journal of Agricultural and Food Chemistry (5 papers)Phytomedicine (3 papers)European Journal of Pharmacology (3 papers)Biomedicine & Pharmacotherapy (2 papers)Chemico-Biological Interactions (2 papers)
- Partner nations
- ChinaNetherlands
In The Last Decade
Yonger Chen
19 papers receiving 601 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Nephrology 116
- Pharmacology 124
- Complementary and alternative medicine 48
- Molecular Medicine 25
- Pathology and Forensic Medicine 80
Countries citing papers authored by Yonger Chen
This map shows the geographic impact of Yonger Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonger Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonger Chen more than expected).
Fields of papers citing papers by Yonger Chen
This network shows the impact of papers produced by Yonger Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonger Chen. The network helps show where Yonger Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yonger Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 141 | |
| 2 | 2021 | 56 | |
| 3 | Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer Hit paper breakdown → | 2024 | 47 |
| 4 | 2020 | 47 | |
| 5 | 2021 | 44 | |
| 6 | Esculin inhibits hepatic stellate cell activation and CCl4-induced liver fibrosis by activating the Nrf2/GPX4 signaling pathway Hit paper breakdown → | 2024 | 41 |
| 7 | 2020 | 35 | |
| 8 | 2022 | 33 | |
| 9 | 2022 | 29 | |
| 10 | 2020 | 28 | |
| 11 | 2023 | 24 | |
| 12 | 2022 | 22 | |
| 13 | 2022 | 19 | |
| 14 | 2023 | 13 | |
| 15 | 2021 | 9 | |
| 16 | 2021 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2024 | 5 | |
| 19 | 2024 | 3 | |
| 20 | 2025 | 0 |
About Yonger Chen
Yonger Chen is a scholar working on Molecular Biology, Epidemiology, Pathology and Forensic Medicine, Genetics and Immunology, having authored 20 papers that have together received 609 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Inflammatory Bowel Disease (4 papers), Vitamin D Research Studies (3 papers), Inflammasome and immune disorders (3 papers), Diet, Metabolism, and Disease (2 papers), Gut microbiota and health (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Nephrology (116 citations), Pharmacology (124 citations), Complementary and alternative medicine (48 citations), Molecular Medicine (25 citations) and Pathology and Forensic Medicine (80 citations). Yonger Chen has collaborated with scholars based in China and Netherlands. Frequent co-authors include Shaozhen Hou, Xin Yuan, Jian Liang, Jian Liang, Yingyu Lu, Shuxian Chen, Jian Liang, Song Huang, Ping Ding and Haiyang Huang. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Phytomedicine, European Journal of Pharmacology, Biomedicine & Pharmacotherapy and Chemico-Biological Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.